Table 4.
Group | A | B | C | D | E |
SVR | NR | Mild recurrence | Too sick | Comorbidity | |
n | 63 | 87 | 73 | 35 | 100 |
No. of deaths at 10 yr after LT, n (%) | 7 (11.1) | 35 (40.2) | 6 (8.2) | 35 (100) | 20 (20) |
Liver related, n (%) | 2 (28.6) | 22 (62.9) | 3 (50) | 11 (31.4) | 10 (50) |
HCV recurrence | 1 | 17 | 2 | 3 | 1 |
HCC | 1 | 4 | 1 | 1 | 8 |
Primary non function | 0 | 0 | 0 | 6 | 0 |
Other liver-related | 0 | 1 | 0 | 1 | 1 |
Non liver-related, n (%) | 5 (71.4) | 13 (37.1) | 3 (50) | 24 (68.6) | 10 (50) |
Cardiac | 1 | 0 | 0 | 0 | 0 |
Renal | 0 | 2 | 0 | 0 | 0 |
Cancer | 0 | 1 | 0 | 3 | 6 |
Infection | 0 | 6 | 1 | 10 | 3 |
Vascular | 0 | 0 | 1 | 0 | 0 |
Other comorbidity | 4 | 4 | 1 | 11 | 1 |
SVR: Sustained virological response; HCC: Hepatocellular carcinoma; NR: Non-response; LT: Liver transplantation.